Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk NVO we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $271,120 and 3, calls, for a total amount of $100,924.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $110.0 for Novo Nordisk over the last 3 months.
Volume & Open Interest Development
In today's trading context, the average open interest for options of Novo Nordisk stands at 1425.0, with a total volume reaching 5,628.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Novo Nordisk, situated within the strike price corridor from $65.0 to $110.0, throughout the last 30 days.
Novo Nordisk Call and Put Volume: 30-Day Overview
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | PUT | SWEEP | BEARISH | 02/21/25 | $3.7 | $3.6 | $3.65 | $83.00 | $137.2K | 374 | 377 |
| NVO | PUT | TRADE | BULLISH | 02/21/25 | $0.17 | $0.06 | $0.1 | $65.00 | $45.0K | 5.5K | 5.0K |
| NVO | PUT | TRADE | BEARISH | 02/14/25 | $3.8 | $3.75 | $3.8 | $84.00 | $38.0K | 125 | 103 |
| NVO | CALL | SWEEP | BULLISH | 02/07/25 | $2.36 | $2.18 | $2.37 | $84.00 | $35.5K | 643 | 9 |
| NVO | CALL | SWEEP | BULLISH | 02/07/25 | $6.65 | $6.55 | $6.6 | $77.00 | $34.3K | 10 | 52 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Where Is Novo Nordisk Standing Right Now?
- With a trading volume of 1,627,289, the price of NVO is down by -1.71%, reaching $83.01.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 2 days from now.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Novo Nordisk with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
